Design analytics pressure test protocols across entire portfolio
DOWNLOAD CASE STUDY: Data-Informed Protocol Assessments Save Time and Money Across Large Pharma Portfolio
A biopharmaceutical company discovered their protocols were needlessly complex and potentially not feasible in clinical delivery. As a result, their clinical development was slower than their large-pharma counterparts. The company needed to improve study design across their portfolio, including ensuring that studies are not too burdensome for patients.
The sponsor partnered with IQVIA to integrate design analytics into their process. Ultimately, Data-Informed Protocol Assessments were conducted on over 50 protocols across the sponsor’s portfolio.
This approach provided the sponsor with insights and key trends that facilitated protocol revisions. These revisions have the potential to save the company millions of dollars and considerably decrease development time.
Understand how a Design Analytics partnership with IQVIA can help you improve study design, decrease patient burden and potentially realize millions in savings. Download the case study now.
